163 related articles for article (PubMed ID: 37119497)
1. Safety Evaluation of a Novel Potentially Probiotic Limosilactobacillus fermentum in Rats.
Cruz Neto JPR; de Oliveira AM; de Oliveira KÁR; Sampaio KB; da Veiga Dutra ML; de Luna Freire MO; de Souza EL; de Brito Alves JL
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):752-762. PubMed ID: 37119497
[TBL] [Abstract][Full Text] [Related]
2. Potentially Probiotic Limosilactobacillus fermentum Fruit-Derived Strains Alleviate Cardiometabolic Disorders and Gut Microbiota Impairment in Male Rats Fed a High-Fat Diet.
de Araújo Henriques Ferreira G; Magnani M; Cabral L; Brandão LR; Noronha MF; de Campos Cruz J; de Souza EL; de Brito Alves JL
Probiotics Antimicrob Proteins; 2022 Apr; 14(2):349-359. PubMed ID: 35066820
[TBL] [Abstract][Full Text] [Related]
3. In vivo safety assessment of Lactobacillus fermentum strains, evaluation of their cholesterol-lowering ability and intestinal microbial modulation.
Thumu SCR; Halami PM
J Sci Food Agric; 2020 Jan; 100(2):705-713. PubMed ID: 31599967
[TBL] [Abstract][Full Text] [Related]
4.
Zafar H; Ain NU; Alshammari A; Alghamdi S; Raja H; Ali A; Siddique A; Tahir SD; Akbar S; Arif M; Alharbi M; Rahman A
Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458216
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of Lactobacillus fermentum post-weaning improves the lipid profile and autonomic dysfunction in rat offspring exposed to maternal dyslipidemia.
de Oliveira Y; Cavalcante RGS; Cavalcanti Neto MP; Magnani M; Braga VA; de Souza EL; de Brito Alves JL
Food Funct; 2020 Jun; 11(6):5581-5594. PubMed ID: 32524104
[TBL] [Abstract][Full Text] [Related]
6. Limosilactobacillus fermentum Strains with Claimed Probiotic Properties Exert Anti-oxidant and Anti-inflammatory Properties and Prevent Cardiometabolic Disorder in Female Rats Fed a High-Fat Diet.
de Luna Freire MO; do Nascimento LCP; de Oliveira KÁR; de Oliveira AM; Dos Santos Lima M; Napoleão TH; da Costa Silva JH; Lagranha CJ; de Souza EL; de Brito Alves JL
Probiotics Antimicrob Proteins; 2023 Jun; 15(3):601-613. PubMed ID: 34817804
[TBL] [Abstract][Full Text] [Related]
7. Pre-clinical safety and toxicity assessment of Limosilactobacillus fermentum NCDC 400 in murine model.
Nataraj BH; Jeevan K; Dang AK; Nagpal R; Ali SA; Behare PV
Microb Pathog; 2024 Apr; 189():106589. PubMed ID: 38382627
[TBL] [Abstract][Full Text] [Related]
8. The molecular mechanisms of probiotic strains in improving ageing bone and muscle of d-galactose-induced ageing rats.
Hor YY; Ooi CH; Lew LC; Jaafar MH; Lau AS; Lee BK; Azlan A; Choi SB; Azzam G; Liong MT
J Appl Microbiol; 2021 Apr; 130(4):1307-1322. PubMed ID: 32638482
[TBL] [Abstract][Full Text] [Related]
9. Limosilactobacillus fermentum Strains as Novel Probiotic Candidates to Promote Host Health Benefits and Development of Biotherapeutics: A Comprehensive Review.
de Luna Freire MO; Cruz Neto JPR; de Albuquerque Lemos DE; de Albuquerque TMR; Garcia EF; de Souza EL; de Brito Alves JL
Probiotics Antimicrob Proteins; 2024 Feb; ():. PubMed ID: 38393628
[TBL] [Abstract][Full Text] [Related]
10. The probiotic Lactobacillus fermentum 296 attenuates cardiometabolic disorders in high fat diet-treated rats.
Cavalcante RGS; de Albuquerque TMR; de Luna Freire MO; Ferreira GAH; Carneiro Dos Santos LA; Magnani M; Cruz JC; Braga VA; de Souza EL; de Brito Alves JL
Nutr Metab Cardiovasc Dis; 2019 Dec; 29(12):1408-1417. PubMed ID: 31640890
[TBL] [Abstract][Full Text] [Related]
11. A Mix of Potentially Probiotic
Carneiro Dos Santos LA; Carvalho RDO; Cruz Neto JPR; de Albuquerque Lemos DE; de Oliveira KÁR; Sampaio KB; de Luna Freire MO; Aburjaile FF; Azevedo VAC; de Souza EL; de Brito Alves JL
Microorganisms; 2024 Mar; 12(4):. PubMed ID: 38674604
[TBL] [Abstract][Full Text] [Related]
12. Beneficial Effects of
Rodríguez-Sojo MJ; Garcia-Garcia J; Ruiz-Malagón AJ; Diez-Echave P; Hidalgo-García L; Molina-Tijeras JA; González-Lozano E; López-Escanez L; Rodríguez-Cabezas ME; Rodríguez-Sánchez MJ; Rodríguez-Nogales A; Mediavilla C; Galvez J
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615683
[TBL] [Abstract][Full Text] [Related]
13. Effects of a Mixed
de Luna Freire MO; do Nascimento LCP; de Oliveira KÁR; de Oliveira AM; Napoleão TH; Lima MDS; Lagranha CJ; de Souza EL; de Brito Alves JL
Foods; 2021 Sep; 10(9):. PubMed ID: 34574313
[TBL] [Abstract][Full Text] [Related]
14. Safety Assessment of the Potential Probiotic Bacterium Limosilactobacillus fermentum J23 Using the Mexican Fruit Fly (Anastrepha ludens Loew, Diptera: Tephritidae) as a Novel In Vivo Model.
Castro-López C; Pascacio-Villafán C; Aluja M; García HS; González-Córdova AF; Vallejo-Cordoba B; Hernández-Mendoza A
Probiotics Antimicrob Proteins; 2024 Feb; 16(1):233-248. PubMed ID: 36574190
[TBL] [Abstract][Full Text] [Related]
15.
Ozen M; Piloquet H; Schaubeck M
Nutrients; 2023 May; 15(9):. PubMed ID: 37432320
[TBL] [Abstract][Full Text] [Related]
16. Safety Assessment of Potential Probiotic Lactobacillus fermentum MTCC-5898 in Murine Model after Repetitive Dose for 28 Days (Sub-Acute Exposure).
Samtiya M; Bhat MI; Gupta T; Kapila S; Kapila R
Probiotics Antimicrob Proteins; 2020 Mar; 12(1):259-270. PubMed ID: 30847835
[TBL] [Abstract][Full Text] [Related]
17. Human oral isolate Lactobacillus fermentum AGR1487 induces a pro-inflammatory response in germ-free rat colons.
Anderson RC; Ulluwishewa D; Young W; Ryan LJ; Henderson G; Meijerink M; Maier E; Wells JM; Roy NC
Sci Rep; 2016 Feb; 6():20318. PubMed ID: 26843130
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models.
Zoumpopoulou G; Foligne B; Christodoulou K; Grangette C; Pot B; Tsakalidou E
Int J Food Microbiol; 2008 Jan; 121(1):18-26. PubMed ID: 18077037
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis.
Peran L; Sierra S; Comalada M; Lara-Villoslada F; Bailón E; Nieto A; Concha A; Olivares M; Zarzuelo A; Xaus J; Gálvez J
Br J Nutr; 2007 Jan; 97(1):96-103. PubMed ID: 17217564
[TBL] [Abstract][Full Text] [Related]
20. Development and in vitro evaluation of novel nutraceutical formulations composed of Limosilactobacillus fermentum, quercetin and/or resveratrol.
Sampaio KB; do Nascimento YM; Tavares JF; Cavalcanti MT; de Brito Alves JL; Garcia EF; de Souza EL
Food Chem; 2021 Apr; 342():128264. PubMed ID: 33041168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
